Portland Gastroenterology Center

What Portland Gastroenterology Center does

Portland Gastroenterology Center (PGC) is an independent, physician-owned gastroenterology specialty practice headquartered at 161 Marginal Way, Portland, Maine, and self-described as the largest and most comprehensive GI practice in the state, serving more than 30,000 patients annually. The practice delivers the full spectrum of digestive-health services — colonoscopy, upper endoscopy (EGD), capsule endoscopy/PillCam, Bravo pH testing, FibroScan liver elastography, endoscopic ultrasound (EUS), flexible sigmoidoscopy, polypectomy, and a dedicated infusion center — through a single AAAHC-accredited endoscopy facility featuring 22 beds and six procedure rooms. Staffing comprises 10 board-certified gastroenterologists with subspecialty training in advanced endoscopy, transplant hepatology, inflammatory bowel disease, and women's GI, supported by 7 family nurse practitioners.

The practice's underlying technology stack centers on advanced endoscopic equipment, AI-enhanced colonoscopy screening for polyp detection, FibroScan non-invasive liver imaging, an electronic medical record, and a patient portal supporting online scheduling, lab results, and secure messaging. Recent capability additions include a clinical trials program (launched 2024) and participation as core faculty in Maine's first gastroenterology fellowship at MaineHealth Maine Medical Center–Portland (2025), creating an academic-clinical hybrid structure uncommon for an independent community practice.

PGC operates a referral-based, sales-led go-to-market: patients are routed from primary care physicians for consultations and procedures, with same-day or next-day scheduling for urgent cases and a four-month target for non-urgent colonoscopies. Revenue is generated through professional services billing (physician fees) and facility fees billed separately, reimbursed primarily via commercial insurance with patient co-pays collected at time of service. No public pricing, revenue, or funding figures are disclosed. Marketing is passive, relying on PCP referrals and a content-driven website rather than paid acquisition, and the practice's growth posture is shaped by leadership under Dr. Noemi Baffy (President since 2024) and Dr. Kate Kennedy (Medical Director).

Name

Portland Gastroenterology Center

Legal name

Portland Gastroenterology Center

Website

https://portlandgastro.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Portland Gastroenterology Center is Maine's largest independent, physician-owned gastroenterology practice, delivering comprehensive digestive-health services — colonoscopy, upper endoscopy, FibroScan, infusion, and advanced endoscopy — through an AAAHC-accredited facility to over 30,000 patients annually, primarily on referral from primary care physicians.

Ownership category

akta.pro rank

Product category

Gastroenterology Healthcare Services

NAICS

Offices of Physicians (62111), Freestanding Ambulatory Surgical and Emergency Centers (621493), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

General Gastroenterology (HLAKAEAA)

akta.pro secondary industries

Endoscopy & GI Procedure Centers (HLAFAIAE), Advanced Endoscopy (ERCP/EUS/Interventional) (HLAKAEAC), Liver & GI Clinical Research (Trials Centers) (HLAKAEAL), Pancreaticobiliary Disorders (HLAKAEAG)

Keywords

• Gastroenterology services
• Colonoscopy screening
• Endoscopy procedures
• Digestive health care
• Liver disease treatment

Headquarters

HQ city

Maine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinical Services Revenue: Revenue generated from patient consultations, procedures, and treatments including colonoscopies, upper endoscopies, and other GI procedures. Billing includes physician fees and facility fees as separate components. Insurance claims are submitted to patient's insurance company with patient responsible for co-pays and deductibles.
2. Procedure Facility Fees: Facility fees charged for procedures performed at the Portland Endoscopy Center, which are billed separately from physician fees regardless of procedure location.
3. Infusion Center Services: Infusion services for patients requiring IV medications for gastroenterology conditions, including dedicated phone prompt (Press 7) for infusion center patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Portland Gastroenterology Center delivers gastroenterology and digestive health services through its AAAHC-accredited endoscopy center in Portland, Maine. Core offerings include colonoscopy, upper endoscopy (EGD), capsule endoscopy (PillCam), Bravo pH testing, FibroScan, endoscopic ultrasound (EUS), flexible sigmoidoscopy, polypectomy, and infusion services for GI conditions. The practice leverages AI-enhanced colonoscopy technology, FibroScan non-invasive liver imaging, and electronic medical records with patient portal access to serve referred and self-referred patients across the full spectrum of gastrointestinal and liver disorders.

Product overview

Portland Gastroenterology Center (PGC) is Maine's largest gastroenterology practice offering a comprehensive suite of digestive health services. The core clinical offerings include colonoscopy (colon cancer screening and prevention), upper endoscopy (EGD), capsule endoscopy/PillCam, Bravo pH testing, Fibroscan, endoscopic ultrasound (EUS), flexible sigmoidoscopy, and polypectomy — all delivered through an AAAHC-accredited endoscopy center with 22 beds and six procedure rooms. The practice enhances its colonoscopy screenings with AI-assisted detection technology, participates in clinical trials, and contributes to a GI fellowship training program. The portfolio spans diagnostic procedures, therapeutic interventions, and educational/research initiatives, unified under a single independent, doctor-owned specialty practice.

Differentiator

Problem solved

Functional benefit

Products and services

• Colonoscopy Visual examination of the inner lining of the colon using a thin, flexible tube with a tiny camera; detects and helps prevent colon cancer by enabling polyp removal during the exam. Indicated for adults age 45+ (or younger with family history) and patients with GI symptoms.
• Upper Endoscopy (EGD) Examination of the lining of the esophagus, stomach, and upper small bowel using a camera at the end of a flexible tube; used to find the source of swallowing problems, abdominal discomfort, reflux, or intestinal bleeding.
• Capsule Endoscopy (PillCam) Patient swallows a pill-sized camera that captures images of the small intestine as it passes through the digestive tract, enabling visualization of areas not reachable by standard endoscopy.
• Bravo pH Testing Esophageal pH monitoring test that evaluates acid reflux symptoms by measuring pH levels in the esophagus over a 24–48 hour period.
• FibroScan Non-invasive imaging tool that measures liver stiffness through vibration-based elastography, providing accurate liver disease assessments without invasive procedures.
• Flexible Sigmoidoscopy Evaluation of part of the colon using a flexible sigmoidoscope, typically requiring only an enema prep; provides a less complete examination than a full colonoscopy.
• Colon Cancer Screening & Diagnostic Services Comprehensive colon cancer screening service including colonoscopy beginning at age 45, with polyp detection and removal to reduce colon cancer risk by up to 90%.
• Endoscopy Center (AAAHC Accredited) Facility-based endoscopy service where colonoscopies and upper endoscopies are performed; Maine's first AAAHC-accredited GI endoscopy facility, providing the setting for the practice's procedural care.
• Infusion Center Services Infusion services for patients requiring IV medications to treat gastroenterology conditions, administered at the practice's infusion center.

Quantifiable outcome

• Colonoscopy can reduce the risk of developing colon cancer by up to 90%
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/portlandgastro
• LinkedInlinkedin.com/company/portland-gastroenterology-center

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Portland Gastroenterology Center